Efficacy of Abdominal Catgut Embedding Combined With Auricular Acupressure Therapy for Obese Patients

Not Applicable

Completed

• Conditions: Acupuncture

• Registration Number: NCT06133205
• Lead Sponsor: China Medical University Hospital

Brief Summary

Objective: obesity is an important risk factor of chronic diseases, which not only threatens people's health, but also an important topic of public health. The purpose of this study is to define obesity according to the norms of the World Health Organization, and to explore whether combined weight loss methods have an impact on weight loss.

Methods:

In this study, Combined treatment of abdominal acupoint catgut embedding was combined with auricular pellet acupressure, The wire used for catgut embedding in the experiment was polydioxanone (PDO) 。 This experiment was divided into two groups: the experimental group A and the control group B 。 The reference measurement basis is the data obtained by "Inbody" instrument, including height and weight, body mass index (BMI), basic metallic rate (BMR), Body Fat Percentage BFP) , waist hip ratio and the data of total cholesterol (TC) and triglycerides (TG) obtained from biochemical blood examination, through the comparison before and after the test, we can judge whether the method of this test can achieve a certain degree of curative effect on weight loss.

Detailed Description

Objective: obesity is an important risk factor of chronic diseases, which not only threatens people's health, but also an important topic of public health. The purpose of this study is to define obesity according to the norms of the World Health Organization, and to explore whether combined weight loss methods have an impact on weight loss.

Methods:

In this study, This study is a random Single Blind Random Blind Trial conducted at Acupuncture and Moxibustion department of China Medical University hospital, Taichung city, Taiwan. The study involved 2 groups divided in 1:1 ratio to an intervention group and a control group. The study Combined treatment of abdominal acupoint catgut embedding was combined with auricular pellet acupressure, The wire used for catgut embedding in the experiment was polydioxanone (PDO) 。 This experiment was divided into two groups: the experimental group and the control group。The reference measurement basis is the data obtained by "Inbody" instrument, including height and weight, body mass index (BMI), basic metallic rate (BMR), Body Fat Percentage BFP), waist hip ratio and the data of total cholesterol (TC) and triglycerides (TG) obtained from biochemical blood examination, through the comparison before and after the test, we can judge whether the method of this test can achieve a certain degree of curative effect on weight loss.

Study Timeline

• Study Start: 2021-12-09
• Primary Completion: 2022-05-31
• Study Completion: 2022-12-31
• Status Verified: 2023-11
• Study First Submitted: 2023-11-10
• Study First Submitted QC: 2023-11-10
• Last Update Submitted: 2023-11-10
• Study First Posted: 2023-11-15
• Last Update Posted: 2023-11-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 44

Inclusion Criteria

A. Age 25 to 45 years old B. In line with the World Health Organization's BMI standard diagnosis ≥ 25 C. Waist circumference of men ≥90 cm or waist circumference of women ≥80 cm D. Body fat rate of men>25%, body fat rate of women>30% E. The above B, C, D can be included if they meet one of them F. Complete written informed consent

Exclusion Criteria

• A. Pregnant, breastfeeding, menopausal women B. There are malignant tumors of the heart, liver and kidneys C. Diagnosed with mental illness D. Participated in another study within three months E. There are people who are taking diet pills

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
body weight	12 weeks	body weight in kilograms measured at inclusion and at 12 weeks measured by "InBody" body analysis instrument
basal metabolic rate	12 weeks	basal metabolic rate measured at inclusion and at 12 weeks measured by "InBody" body analysis instrument
Body fat percentage	12 weeks	Body fat percentage measured at inclusion and at 12 weeks measured by "InBody" body analysis instrument
BMI	12 weeks	Body mass index (BMI) measured at inclusion and at 12 weeks measured by "InBody" body analysis instrument

Secondary Outcome Measures

Name	Time	Method
Triglycerides	12 weeks	Triglycerides levels in blood measured by blood tests on inclusion and at 12 weeks
Skeletal muscle weight	12 weeks	Skeletal muscle weight measured at inclusion and at 12 weeks measured by "InBody" body analysis instrument
Total cholesterol	12 weeks	Total cholesterol levels in blood measured by blood tests on inclusion and at 12 weeks
WHOQOL	12 weeks	WHOQOL numerical assessment of quality of life, fill in the questionnaire before the first treatment.
waist hip ratio	12 weeks	waist hip ratio measured at inclusion and at 12 weeks measured by "InBody" body

Trial Locations

Locations (1)

China Medical University Hospital; 🇨🇳 Taichung, Taiwan